High-dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCT.
Peppone LJ, Kleckner AS, Fung C, Puzas JE, Reschke JE, Culakova E, Inglis J, Kamen C, Friedberg JW, Janelsins M, Mustian K, Heckler CE, Mohile S.
Peppone LJ, et al. Among authors: janelsins m.
Cancer. 2024 Jul 15;130(14):2538-2551. doi: 10.1002/cncr.35275. Epub 2024 Mar 23.
Cancer. 2024.
PMID: 38520382
Free PMC article.
Clinical Trial.